Proposal of the Board of Directors for the appropriation of the available profit
in CHF | 2025 proposal | 2024 actual appropriation | ||
Profit / (loss) for the year | 13’570’776 | 19’032’695 | ||
Unallocated profit carried forward from previous year | 14’643’479 | 16’024’909 | ||
Total available profit | 28’214’255 | 35’057’604 | ||
Ordinary dividend | –4’067’291 | –20’414’125 | ||
Balance carried forward | 24’146’965 | 14’643’479 | ||
Dividend distribution per share | ||||
Gross dividend | 0.10 | 0.50 | ||
Withholding tax (35%) | –0.04 | –0.18 | ||
Net dividend | 0.06 | 0.32 |
The Board of Directors proposes the payment of a dividend of CHF 0.10 per share to the Annual General Meeting on April 16, 2026.
The company will not pay a dividend on treasury shares held by medmix Ltd or one of its subsidiaries. For the 2025 dividend proposal, the ordinary dividend is calculated based on 41’262’370 issued shares, reduced by 589’461 treasury shares held as of December 31, 2025, resulting in 40’672’909 dividend‑entitled shares.